Joel Greenblatt’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$59.7M Buy
251,494
+74,298
+42% +$15.4M 0.14% 123
2026
Q1
$37.4M Buy
177,196
+10,984
+7% +$2.37M 0.11% 211
2025
Q4
$34.2M Buy
166,212
+33,203
+25% +$6.25M 0.12% 185
2025
Q3
$20.9M Buy
133,009
+21,077
+19% +$3.26M 0.09% 300
2025
Q2
$18.8M Buy
111,932
+73,237
+189% +$10.9M 0.11% 219
2025
Q1
$5.33M Buy
38,695
+12,061
+45% +$1.54M 0.04% 507
2024
Q4
$3.15M Sell
26,634
-2,981
-10% -$348K 0.03% 620
2024
Q3
$3.27M Sell
29,615
-38,842
-57% -$4.06M 0.03% 600
2024
Q2
$6.73M Sell
68,457
-4,872
-7% -$496K 0.09% 332
2024
Q1
$8.21M Buy
73,329
+8,917
+14% +$962K 0.12% 200
2023
Q4
$6.49M Buy
64,412
+9,679
+18% +$960K 0.12% 208
2023
Q3
$4.75M Sell
54,733
-50,305
-48% -$4.55M 0.1% 278
2023
Q2
$9.93M Buy
105,038
+36,522
+53% +$3.08M 0.22% 65
2023
Q1
$5.17M Sell
68,516
-41,622
-38% -$3.14M 0.13% 187
2022
Q4
$8.47M Sell
110,138
-34,861
-24% -$2.65M 0.24% 73
2022
Q3
$9.67M Buy
144,999
+138,227
+2,041% +$8.76M 0.29% 46
2022
Q2
$354K Buy
+6,772
New +$385K 0.01% 881
2021
Q1
Sell
-44,718
Closed -$2.4M 993
2020
Q4
$2.4M Sell
44,718
-41,098
-48% -$2.13M 0.08% 311
2020
Q3
$4.03M Sell
85,816
-58,249
-40% -$2.99M 0.13% 217
2020
Q2
$7.52M Buy
+144,065
New +$7.43M 0.23% 117
2020
Q1
Sell
-107,580
Closed -$5.44M 1088
2019
Q4
$5.44M Sell
107,580
-233,297
-68% -$12M 0.1% 257
2019
Q3
$16.1M Buy
340,877
+45,273
+15% +$2.07M 0.28% 102
2019
Q2
$13.9M Sell
295,604
-111,609
-27% -$5.15M 0.22% 133
2019
Q1
$19.6M Sell
407,213
-30,358
-7% -$1.52M 0.29% 95
2018
Q4
$19.5M Buy
437,571
+1,246
+0.3% +$64.9K 0.3% 90
2018
Q3
$23.6M Sell
436,325
-138,058
-24% -$7.07M 0.33% 88
2018
Q2
$28M Buy
+574,383
New +$32.6M 0.41% 63
2018
Q1
Sell
-277,754
Closed -$17M 951
2017
Q4
$17M Buy
+277,754
New +$17.2M 0.25% 124
2017
Q1
Sell
-74,164
Closed -$5.34M 996
2016
Q4
$5.34M Sell
74,164
-517,693
-87% -$37.4M 0.07% 368
2016
Q3
$46M Sell
591,857
-176,515
-23% -$14.3M 0.6% 22
2016
Q2
$59.9M Buy
768,372
+529,878
+222% +$42.2M 0.72% 18
2016
Q1
$19.5M Buy
238,494
+232,649
+3,980% +$18.9M 0.22% 148
2015
Q4
$522K Sell
5,845
-254,210
-98% -$21.6M 0.01% 691
2015
Q3
$20M Buy
260,055
+58,852
+29% +$4.92M 0.19% 175
2015
Q2
$16.8M Sell
201,203
-34,314
-15% -$3.03M 0.14% 230
2015
Q1
$21.3M Sell
235,517
-7,870
-3% -$678K 0.16% 219
2014
Q4
$19.6M Sell
243,387
-110,232
-31% -$8.71M 0.16% 215
2014
Q3
$26.5M Sell
353,619
-326,443
-48% -$23.8M 0.26% 137
2014
Q2
$46.6M Buy
680,062
+300,754
+79% +$20.5M 0.58% 19
2014
Q1
$26.5M Buy
379,308
+121,983
+47% +$8.48M 0.4% 59
2013
Q4
$17.2M Buy
257,325
+113,419
+79% +$6.93M 0.41% 44
2013
Q3
$7.5M Buy
143,906
+127,419
+773% +$6.47M 0.24% 117
2013
Q2
$778K Buy
+16,487
New +$753K 0.03% 583

Other funds holding CAH

Joel Greenblatt's CAH Position: Q2 2026 in Review

Joel Greenblatt increased its Cardinal Health (CAH) stake by 42% in Q2 2026, buying an estimated $15.4M and bringing the position to 251,494 shares worth $59.7M. The position accounts for 0.14% of the portfolio, ranked #123.

Joel Greenblatt first reported a position in CAH in Q2 2013 and has held it in 43 quarters since. The position peaked at $59.9M in Q2 2016. 1,490 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • Joel Greenblatt held 251,494 shares of Cardinal Health worth $59.7M as of Q2 2026.
  • Joel Greenblatt bought 74,298 Cardinal Health shares in Q2 2026, an estimated $15.4M.
  • Cardinal Health made up 0.14% of Joel Greenblatt's portfolio in Q2 2026, its #123 holding.
  • Joel Greenblatt first reported a position in Cardinal Health in Q2 2013 and has held it in 43 quarters since.
  • Joel Greenblatt's Cardinal Health position peaked at $59.9M in Q2 2016.
  • 1,490 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on Gotham Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.